Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience
- PMID: 37842310
- PMCID: PMC10570793
- DOI: 10.3389/fendo.2023.1266728
Cardiovascular and metabolic status in patients with primary hyperparathyroidism: a single-center experience
Abstract
Introduction: Cardiovascular diseases (CVD) and metabolic disorders (MD) have retained leading positions in the structure of morbidity and mortality for many years. Primary hyperparathyroidism (PHPT) is also associated with a greater incidence of CVD and MD. The aim of the present study was to describe the prevalence and structure of CVD and MD in hospitalized patients with PHPT and to search for possible associations between these pathologies.
Methods: 838 patients with a verified PHPT were included in the study. The studied cohort was divided into 2 groups according to their age at the time of admission: patients aged 18 to 49 years (group A, n = 150); patients aged 50 years and older (group B, n = 688).
Results: There were no significant differences between two groups in parameters of calcium-phosphorus metabolism. Obesity was diagnosed in 24.2% of patients in group A and in 35.9% in group B. Type 2 diabetes mellitus was more common in older patients (14.4% in group B vs. 2.6% in group A). Arterial hypertension, ischemic heart disease, chronic heart failure and brachiocephalic arteries atherosclerosis were more frequent in older patients, occurring in 79.1%, 10.8%, 8.4%, and 84% of cases respectively. The cutoff points that increased the risk of CVD detection turned out to be age above 56 years, eGFR below 92 ml/min/1.73m2, BMI above 28.3 kg/m2.
Discussion: The present study demonstrated a high incidence of some CVD, as well as disorders of lipid, carbohydrate and purine metabolism in patients with PHPT.
Keywords: arterial hypertension; cardiovascular diseases; diabetes mellitus; dyslipidemia; metabolic diseases; primary hyperparathyroidism.
Copyright © 2023 Dobreva, Gorbacheva, Bibik, Eremkina, Elfimova, Salimkhanov, Kovaleva, Maganeva and Mokrysheva.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Cardiovascular Risk in Patients with Primary Hyperparathyroidism.Curr Pharm Des. 2020;26(43):5628-5636. doi: 10.2174/1381612824999201105165642. Curr Pharm Des. 2020. PMID: 33155899 Review.
-
Cardiovascular risk factors and arterial rigidity are similar in asymptomatic normocalcemic and hypercalcemic primary hyperparathyroidism.Eur J Endocrinol. 2010 May;162(5):925-33. doi: 10.1530/EJE-09-1067. Eur J Endocrinol. 2010. PMID: 20421337
-
Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism.J Endocrinol Invest. 2012 Jun;35(6):548-52. doi: 10.3275/7861. Epub 2011 Jul 12. J Endocrinol Invest. 2012. PMID: 21750400
-
A record linkage study of outcomes in patients with mild primary hyperparathyroidism: the Parathyroid Epidemiology and Audit Research Study (PEARS).Clin Endocrinol (Oxf). 2011 Aug;75(2):169-76. doi: 10.1111/j.1365-2265.2010.03958.x. Clin Endocrinol (Oxf). 2011. PMID: 21158894
-
Impact of parathyroidectomy on cardiovascular risk in primary hyperparathyroidism: A narrative review.Nutr Metab Cardiovasc Dis. 2021 Apr 9;31(4):981-996. doi: 10.1016/j.numecd.2020.12.029. Epub 2021 Jan 5. Nutr Metab Cardiovasc Dis. 2021. PMID: 33612382 Review.
Cited by
-
Lipoprotein alterations in endocrine disorders - a review of the recent developments in the field.Front Endocrinol (Lausanne). 2024 Apr 2;15:1354098. doi: 10.3389/fendo.2024.1354098. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38628593 Free PMC article. Review.
-
Primary Hyperparathyroidism: An Analysis Amid the Co-Occurrence of Type 2 Diabetes Mellitus.Life (Basel). 2025 Apr 21;15(4):677. doi: 10.3390/life15040677. Life (Basel). 2025. PMID: 40283231 Free PMC article. Review.
References
-
- Kumari P, Arya AK, Pal R, Sood A, Dahiya D, Mukherjee S, et al. . Comparison of profile of primary hyperparathyroidism with and without type 2 diabetes mellitus: Retrospective analysis from the Indian primary hyperparathyroidism registry. Endocr Pract (2022) 28(1):96–101. doi: 10.1016/j.eprac.2021.09.012 - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous